PRPH 8-K 2026-01-09

ProPhase Labs, Inc. (PRPH) 8-K dated 2026-01-09 — accession 0001493152-26-001134.

ProPhase Labs, Inc. (PRPH) is a diagnostics & research company listed on US.

ProPhase Labs, Inc. filed a 8-K on 2026-01-09. Accession 0001493152-26-001134.

This 8-K covers: Director/officer change (Item 5.02). SEC EDGAR holds the official filing and its exhibits.

Latest reported PRPH revenue for 2025-12-31 was $4.3M. Net income was -$14.7M. Revenue was down 90.2% from 2023-12-31 to 2025-12-31. PRPH currently screens at market cap $1.8M.

Not investment advice. The PRPH SEC hub lists recent forms. The stock page is the research view.